Sign In
Buy AZN
$181.02
+4.59 (+2.60%)
At Close: Jun 23, 2026
FDA Rejects AstraZeneca's Saphnelo Injection, Shares Drop 1.9%
11:48am, Tuesday, 03'rd Feb 2026
AstraZeneca (AZN) shares moved lower after the US Food and Drug Administration issued a complete response letter declining approval of a self-administered versi
AstraZeneca's Initial Application for Lupus Injection Turned Down by FDA
02:42am, Tuesday, 03'rd Feb 2026
The company is working with the U.S. regulator to move forward with an updated application, adding a decision is expected in the first half of 2026.
US FDA rejects AstraZeneca's easier-to-use version of lupus therapy
02:18am, Tuesday, 03'rd Feb 2026
AstraZeneca said on Tuesday that the U.S. health regulator had rejected its application for an easier-to-use version of lupus therapy Saphnelo, pushing back the timeline for a possible approval to the
AstraZeneca Moves to NYSE as $50 Billion US Investment Plan Takes Focus
12:29pm, Monday, 02'nd Feb 2026
AstraZeneca (AZN) is set to begin trading on the New York Stock Exchange on Monday, replacing its American Depositary Receipts that had been listed on Nasdaq, i
AZN Obesity Pipeline to Get a Boost From Deal With China's CSPC
12:00pm, Monday, 02'nd Feb 2026
AstraZeneca deepens its obesity push with an eight-program deal with China's CSPC, securing rights to a once-monthly injectable weight-management pipeline.
AstraZeneca begins trading on the New York Stock Exchange
07:00am, Monday, 02'nd Feb 2026
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today begins trading its ordinary shares on the New York Stock Exchange (NYSE) for the first time, enabling more US investors to participate in the Compa
AstraZeneca begins trading directly on the NYSE
03:09am, Monday, 02'nd Feb 2026
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares start trading directly on the New York Stock Exchange today, establishing a harmonised global listing along with London and Stockholm. Up to now, US inves
AstraZeneca begins trading directly on the NYSE
02:51am, Monday, 02'nd Feb 2026
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares start trading directly on the New York Stock Exchange today, establishing a harmonised global listing along...
AstraZeneca is listing in New York, as Big Pharma balances the huge U.S. market with China's tempting innovation
02:49am, Sunday, 01'st Feb 2026
AstraZeneca has announced it's investing $15 billions in China, and said it is partnering with a Chinese biotech to develop weight-loss drugs. The developments come at a critical time for the pharma i
FTSE 100 Live: London stocks recover as markets cheer Fed chair nomination
08:54am, Friday, 30'th Jan 2026
FTSE 100 gains 27 points to 10,199 Gold, silver and copper retreat from recent highs Fed chair nomination expected today US index futures sink 1.53pm:...
AstraZeneca obesity tie-up with CSPC seen as shrewd move
08:08am, Friday, 30'th Jan 2026
AstraZeneca PLC's (LSE:AZN, NASDAQ:AZN) licensing deal on Friday signals a plausible effort by the FTSE 100 group to grab a piece of a booming market for obesity treatments, analysts said, with still
AstraZeneca Agrees Up to $18.5 Billion Obesity Drug Deal in China
07:52am, Friday, 30'th Jan 2026
AstraZeneca (AZN) is stepping more assertively into the obesity drug race, agreeing to pay China's CSPC Pharmaceutical Group up to $18.5 billion for a broad por
FTSE 100 Live: London stocks recover as markets await Fed chair nomination
05:25am, Friday, 30'th Jan 2026
FTSE 100 gains 13 points to 10,185 Gold, silver and copper retreat from recent highs Fed chair nomination expected today US index futures sink 10.25am:...
FTSE 100 Live: Stocks recover but miners come under pressure as metals retreat
04:10am, Friday, 30'th Jan 2026
FTSE 100 gains 6 points to 10,178 Gold, silver and copper retreat from recent highs Fed chair nomination expected today 9.10am: Greenback "back in the...
AstraZeneca Strikes Multibillion-Dollar Obesity Deal With China's CSPC
02:51am, Friday, 30'th Jan 2026
The agreement to gain rights outside of China to a portfolio of experimental obesity and diabetes drugs could be valued at billions of dollars.
